Abstract:Background Helicobacter pylori treatment failure remains a challenging problem. This study aimed to identify predictive factors for successful eradication in patients following treatment failures. Methods This was a retrospective cohort study. This study included 1,050 dyspeptic patients diagnosed with H . pylori infection at tertiary care center in Thailand between March 2014 and October 2021. Patients’ demographic data, endoscopic findings, H . pylori culture, antimicrobial susceptibility testing (AST), treatment regimens and outcomes were analysed. Results Of 1,050 patients with H . pylori infections, 302 (28.7%) experienced treatment failure (mean age 58.4 years; 44.7% males). AST was performed in 192. Resistance was observed for metronidazole (43.2%), levofloxacin (33.9%), clarithromycin (24%), and amoxicillin (2.1%). There was no tetracycline resistance. Multidrug-resistance (MDR) was significantly more common following treatment failure (45.5% vs. 15.7%, p<0.001). Baseline characteristics were similar between treatment successes and failures. Eradication rates after first-line and second-line regimens were 71.2% and 54.5%, respectively. Medication nonadherence [ OR 36.6 (95%CI 8.65–155.03, p<0.001) ] and MDR [ OR 4.49 (95%CI 2.29–8.81, p<0.001) ] were associated with treatment failure. Over time, resistance increased for metronidazole, levofloxacin, and clarithromycin, while eradication rates with triple therapy declined. Tailored antibiotic therapy [ OR 4.92 (95%CI 1.61–14.99, p = 0.005 )] and a regimen including 4-times-daily dosing of amoxicillin (2 grams/day) [ OR 3.05 (95%CI 1.10–8.41, p = 0.032) ] were significantly associated with treatment success after first-line failure. Eradication rates when using tailored therapy and 4-times-daily dosing of amoxicillin (2 grams/day) were 91.1% and 89.4%, respectively. Performing AST before first-line therapy resulted in the highest cure rates. AST performed after multiple treatment failures was also associated with higher eradication rates compared with the group without AST (94.4% vs. 50%,p = 0.008). Conclusions AST either before or after treatment failure correlated with a higher proportion of successful eradication. Nonadherence and the MDR infections predicted treatment failure. Tailored therapy and 4-times-daily dosing of amoxicillin after treatment failure were likely to be successful.

Helicobacter pylori infection treatment in the United States: clinical consequences and costs of eradication treatment failure

Current Status of Helicobacter Pylori Eradication and Risk Factors for Eradication Failure

Short-term Outcomes and Intermediate-Term Follow-Up of Helicobacter Pylori Infection Treatment for Naïve Patients: a Retrospective Observational Study.

Efficacy of quadruple therapy with clarithromycin based on faecal molecular antimicrobial susceptibility tests as first-line treatment for <i>Helicobacter pylori</i> infection: a protocol of a single-centre, single-blind, randomised clinical trial in China

Diagnosis and treatment patterns among patients with newly diagnosed Helicobacter pylori infection in the United States 2016-2019

Effect of Helicobacter Pylori Eradication on Hyperplastic Gastric Polyps: A Systematic Review and Meta‐analysis

Effectiveness of Helicobacter pylori Therapies in a Clinical Practice Setting

Review: eradication of Helicobacter pylori. Problems and recommendations

Strategy for the Treatment of Helicobacter pylori Infection

Is Short-Term Therapy Really Sufficient to Eradicate Helicobacter Pylori Infection?

Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial)

The status and progress of first-line treatment against Helicobacter pylori infection: a review

Helicobacter pylori-related diseases

The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis

Persistent Helicobacter pylori Infection: An Insight to the Limitations of Current Clinical Practice

How Well Is Helicobacter pylori Treated in Usual Practice?

Helicobacter pylori: today's treatment, and possible future treatment

Eradication Treatment of Helicobacter pylori Infection Based on Molecular Pathologic Antibiotic Resistance

Helicobacter Pylori: A Review of Current Treatment Options in Clinical Practice

Eradication of Helicobacter pylori: recent advances in treatment